Extended-release quetiapine fumarate (quetiapine XR): a once-daily monotherapy effective in generalized anxiety disorder. Data from a randomized, double-blind, placebo- and active-controlled study
This study (Silver: D1448C00011) was supported by AstraZeneca Pharmaceuticals.
| Autores: | , , , , , , |
|---|---|
| Tipo de documento: | artigo |
| Data de publicação: | 2010 |
| País: | España |
| Recursos: | Universidad de Oviedo (UNIOVI) |
| Repositório: | RUO. Repositorio Institucional de la Universidad de Oviedo |
| Idioma: | inglês |
| OAI Identifier: | oai:digibuo.uniovi.es:10651/6622 |
| Acesso em linha: | http://hdl.handle.net/10651/6622 https://dx.doi.org/10.1017/S1461145709990423 |
| Access Level: | Acceso aberto |
| Resumo: | This study (Silver: D1448C00011) was supported by AstraZeneca Pharmaceuticals. |
|---|